Evaluation of HOCl-generating anticancer agents by an ultrasensitive dual-mode fluorescent probe

was used to monitor the oxidative stress process induced by elesclomol in live cancer cells, and using this probe it was further discovered that an evodiamine derivative was capable of generating cancer-cell HOCl.